[Telomerase inhibitor, telomestatin, a specific mechanism to interact with telomere structure]
- PMID: 15283144
[Telomerase inhibitor, telomestatin, a specific mechanism to interact with telomere structure]
Abstract
A novel telomerase inhibitor, telomestatin, isolated from Streptomyces anulatus is the most potent telomerase inhibitor so far. Telomestatin specifically inhibited telomerase without affecting reverse transcriptases and polymerases. In addition, telomestatin induced telomere shortening, but its ratio was extremely faster than that observed in physiological telomere shortening. These results suggested the existence of other mechanisms to inhibit telomerase. Telomeres consist of guanine rich sequences which compose a characteristic three-dimensional structure designated as G-quadruplex. Stabilization of G-quadruplex structure inhibited the catalysis of not only telomerase but also other DNA interacting molecules. Telomestatin potently stabilized G-quadruplex structure in a specific manner. G-quadruplex structure is also involved in a lot of oncogene promoters. Thus, telomestatin provide the novel therapeutic molecular target for cancer chemotherapy.
Similar articles
-
The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.Cancer Res. 2003 Jun 15;63(12):3247-56. Cancer Res. 2003. PMID: 12810655
-
A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.Int J Oncol. 2004 Jun;24(6):1481-7. Int J Oncol. 2004. PMID: 15138591
-
Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.Eur J Cancer. 2005 Dec;41(18):2873-81. doi: 10.1016/j.ejca.2005.08.025. Epub 2005 Oct 25. Eur J Cancer. 2005. PMID: 16253503
-
G-quadruplexes as therapeutic targets.Biopolymers. 2000-2001;56(3):195-208. doi: 10.1002/1097-0282(2000)56:3<195::AID-BIP10009>3.0.CO;2-5. Biopolymers. 2000. PMID: 11745111 Review.
-
Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.Eur J Cancer. 2005 May;41(7):971-9. doi: 10.1016/j.ejca.2004.11.024. Eur J Cancer. 2005. PMID: 15862745 Review.
Cited by
-
FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability.Mol Cell Biol. 2008 Jun;28(12):4116-28. doi: 10.1128/MCB.02210-07. Epub 2008 Apr 21. Mol Cell Biol. 2008. PMID: 18426915 Free PMC article.
-
Specialization among iron-sulfur cluster helicases to resolve G-quadruplex DNA structures that threaten genomic stability.J Biol Chem. 2013 Sep 27;288(39):28217-29. doi: 10.1074/jbc.M113.496463. Epub 2013 Aug 9. J Biol Chem. 2013. PMID: 23935105 Free PMC article.
-
Telomerase Inhibition in the Treatment of Leukemia: A Comprehensive Review.Antioxidants (Basel). 2024 Mar 30;13(4):427. doi: 10.3390/antiox13040427. Antioxidants (Basel). 2024. PMID: 38671875 Free PMC article. Review.
-
FANCJ helicase operates in the Fanconi Anemia DNA repair pathway and the response to replicational stress.Curr Mol Med. 2009 May;9(4):470-82. doi: 10.2174/156652409788167159. Curr Mol Med. 2009. PMID: 19519404 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources